Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer

• Main Authors: Yihang Qi (Author), Wenxiang Zhang (Author), Ray Jiang (Author), Olivia Xu (Author), Xiangyi Kong (Author), Lin Zhang (Author), Yi Fang (Author), Jingping Wang (Author), Jing Wang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The combination of immune checkpoint inhibitors (ICIs) and chemotherapy (CT) is a new strategy to explore cancer treatment in recent years, and it is also practiced in triple-negative breast cancer (TNBC). However, several published randomized controlled trials (RCTs) reported heterogene...